PUBLISHER: The Business Research Company | PRODUCT CODE: 1939213
PUBLISHER: The Business Research Company | PRODUCT CODE: 1939213
Ambulatory IV infusion pumps are portable medical devices designed for the controlled delivery of medication into the patient's body.
The ambulatory IV infusion pumps market, as covered in this report, is segmented by type into disposable infusion pumps and chemotherapy infusion pumps. Disposable infusion pumps are single-use devices utilized for the controlled delivery of medication into the patient's body. These pumps find applications in various medical fields such as chemotherapy/oncology, diabetes, gastroenterology, analgesia/pain management, pediatrics/neonatology, hematology, and other medical applications. These devices are employed by a range of end-users including hospitals, home healthcare, and others.
Tariffs are impacting the ambulatory iv infusion pumps market by increasing costs of imported sensors, microcontrollers, motors, batteries, and precision plastic components. Device manufacturers in North America and Europe are most affected due to reliance on imported electronics, while Asia-Pacific faces higher export-related costs. These tariffs are increasing device prices and slowing adoption in home healthcare settings. However, they are also encouraging domestic assembly, localized component sourcing, and innovation in simplified and cost-optimized pump designs.
The ambulatory iv infusion pumps market research report is one of a series of new reports from The Business Research Company that provides ambulatory iv infusion pumps market statistics, including ambulatory iv infusion pumps industry global market size, regional shares, competitors with a ambulatory iv infusion pumps market share, detailed ambulatory iv infusion pumps market segments, market trends and opportunities, and any further data you may need to thrive in the ambulatory iv infusion pumps industry. This ambulatory iv infusion pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The ambulatory iv infusion pumps market size has grown steadily in recent years. It will grow from $0.91 billion in 2025 to $0.95 billion in 2026 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to growth in outpatient treatment models, increasing prevalence of chronic diseases, early adoption of ambulatory infusion technologies, expansion of home healthcare services, improvements in pump safety mechanisms.
The ambulatory iv infusion pumps market size is expected to see steady growth in the next few years. It will grow to $1.15 billion in 2030 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to increasing demand for remote therapy management, rising integration of connected healthcare devices, expansion of personalized drug delivery solutions, growing focus on reducing hospital stays, advancements in battery efficiency and pump miniaturization. Major trends in the forecast period include increasing adoption of portable and wearable infusion pumps, rising demand for home-based infusion therapies, growing integration of smart dose monitoring features, expansion of multi-therapy pump applications, enhanced focus on patient mobility and comfort.
The rising number of surgical procedures is expected to drive the growth of the ambulatory IV infusion pumps market. Surgical procedures involve medical interventions that require incisions or invasive techniques to access and treat internal or external areas of the body. Ambulatory IV infusion pumps provide controlled administration of fluids, medications, and anesthetics during these procedures, ensuring precise and continuous delivery, which enhances patient safety and surgical efficiency. For instance, in July 2025, according to the American Med Spa Association, a US-based provider of legal, compliance, and business resources for medical spas and aesthetic practices, cosmetic procedure volumes increased by 42.5% over the past four years, reaching 20.5 million non-surgical treatments and 17.4 million surgical procedures in 2024. This rise in surgical procedures is driving demand for ambulatory IV infusion pumps.
Major companies in the ambulatory IV infusion pumps market are focusing on innovations such as precision infusion pumps to improve accuracy, consistency, and data reliability in infusion therapy. Precision infusion pumps are advanced devices designed to deliver medications and fluids with highly controlled accuracy while minimizing variability under different clinical conditions. For instance, in April 2025, ICU Medical, a US-based manufacturer of medical infusion technologies, launched the Plum Solo and Plum Duo precision IV pumps. These devices feature high-accuracy delivery mechanisms supported by integrated digital functions to improve infusion consistency, regardless of environmental or setup factors. The pumps expand a unified infusion platform that strengthens medication management, supports full electronic health record interoperability, and provides clinicians with more reliable real-time infusion data.
In May 2025, ICU Medical, a US-based provider of infusion therapy systems and ambulatory IV infusion pumps, partnered with Otsuka Pharmaceutical Factory, Inc. to enhance IV solutions manufacturing capacity and innovation in North America. The partnership aims to improve supply chain resiliency and introduce advanced PVC-free IV solution technologies to better support healthcare providers. Otsuka Pharmaceutical Factory, Inc. is a Japan-based company specializing in clinical nutrition products and IV solutions produced across its global manufacturing network.
Major companies operating in the ambulatory iv infusion pumps market are Baxter International Inc, Becton Dickinson and Company, B. Braun Melsungen AG, Fresenius Kabi AG, ICU Medical Inc, Medtronic plc, Mindray Medical International Limited, Nipro Corporation, Moog Inc, Zyno Medical LLC, Micrel Medical Devices SA, JMS Co Ltd, Eitan Medical, SOOIL Development Co Ltd, Ypsomed Holding AG, Arcomed AG, Comen Medical, Flowonix Medical, Akas Infusion, CME Medical
North America was the largest region in the ambulatory IV infusion pumps market in 2025. Western Europe was the second largest region in the global ambulatory IV infusion pump market. The regions covered in the ambulatory iv infusion pumps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the ambulatory iv infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The ambulatory IV infusion pumps market consists of sales of disposable infusion pumps and chemotherapy infusion pumps. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Ambulatory IV infusion Pumps Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses ambulatory iv infusion pumps market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for ambulatory iv infusion pumps ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ambulatory iv infusion pumps market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.